TrialTechnology in cancer research & treatment
CT Perfusion Blood Flow Provides an Early Response Marker for Progression-free Survival in a Prospective Randomized Clinical Trial of Metastatic Renal Cell Carcinoma.
Chaan S Ng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.